R92.322
Mammographic fibroglandular density, left breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Mammographic fibroglandular density refers to how dense the breast tissue appears on a mammogram. This density is due to the amount of fibrous and glandular tissue present in the breast versus fatty tissue. A classification known as R92.322 indicates increased density in the left breast, which can impact mammogram interpretations and breast cancer screening accuracy. While having dense breast tissue is common, it's important for women to understand what it means for their health and screening procedures.
Causes & Symptoms
Clinical Causes: Genetic factors influencing breast tissue composition Hormonal influences, particularly during puberty, pregnancy, or menopause Age-related changes in breast tissue Hormone replacement therapy or oral contraceptives Breast tissue composition varies from person to person
Key Symptoms: No noticeable symptoms; dense tissue is usually detected on mammogram Possible difficulty in interpreting mammogram images due to tissue density Increased awareness of breast changes, although dense tissue itself often causes no pain or symptoms
Diagnostic & Treatment
Diagnosis Path: The diagnosis of fibroglandular density is made through mammographic imaging, where radiologists assess the amount of dense tissue in the breast. Mammograms categorize breast tissue into patterns, with denser patterns appearing brighter on the images. It is important to inform the imaging technician and radiologist if there is a suspicion or knowledge of dense breast tissue, as this can influence screening strategies.
Treatment Protocols: There is no specific treatment required for fibroglandular density itself, as it is a normal variant of breast tissue. However, managing overall breast health involves regular screening and awareness of other breast changes. Additional imaging techniques, such as ultrasound or MRI, may be recommended if dense tissue complicates mammogram clarity. Patients are encouraged to discuss screening options and any concerns with their healthcare provider.
Clinical Advice & FAQs
Billing Guidance
Is R92.322 a billable ICD-10 code?
Yes, R92.322 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R92.322?
Clinical documentation must specify the nature of Mammographic fibroglandular density, left breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference